The Patent Finder

Terms ending in 2033

Pharmacyclics, Inc.

Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,133,134Inhibitors of Bruton's Tyrosine Kinase
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 9,713,617Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 9,725,455Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 9,828,383Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 10,065,968Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 10,106,548Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 10,125,140Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 10,266,540Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 10,294,231Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 10,294,232Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
8 more term ends in 2033 · Pro
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Upgrade to Pro
17 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited